Assignee
GUANGZHOU CELLPROTEK PHARM CO LTD
CN·9 granted patents·2 citations·filing 2014–2023
Top patents by PatentIndex Score
9 records- 0176US10835539B2Neuro-protective agents and uses thereofGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2019·Granted Nov 17, 2020·1 cites·6 claims
- 0273US12319750B2Hexokinase 2-specific inhibitors for use in acute central nervous system injuryGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2023·Granted Jun 3, 2025·0 cites·3 claims
- 0373US11584802B2Hexokinase 2-specific inhibitors for use in acute central nervous system injuryGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Feb 21, 2023·1 cites·3 claims
- 0464US9944673B2Crystalline forms of 5α-androstane-3β,5,6β-triol and preparation methods thereforGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2017·Granted Apr 17, 2018·0 cites·4 claims
- 0564US9944672B2Crystalline forms of 5α-androstane-3β,5,6β-triol and preparation methods thereforGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2017·Granted Apr 17, 2018·0 cites·4 claims
- 0649US11911396B2Use of compound in preparation of drug for treating cerebral small vessel diseaseGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Feb 27, 2024·0 cites·14 claims
- 0749US11382921B2Use of compounds in preparation of a medicament for treatment of hemorrhagic strokeGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Jul 12, 2022·0 cites·18 claims
- 0845US9428539B22β,3α,5α-trihydroxy-androst-6-one and preparation methods and use thereofGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2014·Granted Aug 30, 2016·0 cites·6 claims
- 0931US10357500B2Neuro-protective agents and uses thereofGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2015·Granted Jul 23, 2019·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when GUANGZHOU CELLPROTEK PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →